Centene Corp (CNC) stock
CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 7/307% above fair value
$72.55−2.22 (-2.97%)
Close on Nov 17, 2026Market cap $35.92BP/E 24.8Yield –
Centene operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Centene's operating income for the twelve months ending Sep 30, 2026 was $1.01B. For fiscal 2025 it was -$7.62B, down 340.1% from the year before. The highest annual figure on record is $3.18B in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.62B | -340.1% |
| FY2024 | Dec 31, 2024 | $3.18B | +8.4% |
| FY2023 | Dec 31, 2023 | $2.93B | +122.3% |
| FY2022 | Dec 31, 2022 | $1.32B | -26.1% |
| FY2021 | Dec 31, 2021 | $1.78B | -42.1% |
| FY2020 | Dec 31, 2020 | $3.08B | +73.0% |
| FY2019 | Dec 31, 2019 | $1.78B | +22.2% |
| FY2018 | Dec 31, 2018 | $1.46B | +21.6% |
| FY2017 | Dec 31, 2017 | $1.20B | -5.1% |
| FY2016 | Dec 31, 2016 | $1.26B | +79.1% |
| FY2015 | Dec 31, 2015 | $705.00M | +51.9% |
| FY2014 | Dec 31, 2014 | $464.00M | +67.5% |
| FY2013 | Dec 31, 2013 | $277.00M | +156.5% |
| FY2012 | Dec 31, 2012 | $108.00M | -47.0% |
| FY2011 | Dec 31, 2011 | $203.80M | +29.8% |
| FY2010 | Dec 31, 2010 | $157.07M | +13.7% |
| FY2009 | Dec 31, 2009 | $138.14M | +5.0% |
| FY2008 | Dec 31, 2008 | $131.56M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$307.00M | – |
| Q2 FY2026 | Jun 30, 2026 | $1.20B | – |
| Q1 FY2026 | Mar 31, 2026 | $1.86B | +21.3% |
| Q4 FY2025 | Dec 31, 2025 | -$1.75B | -1097.1% |
| Q3 FY2025 | Sep 30, 2025 | -$6.95B | -1145.7% |
| Q2 FY2025 | Jun 30, 2025 | -$458.00M | -137.3% |
| Q1 FY2025 | Mar 31, 2025 | $1.53B | +38.7% |
| Q4 FY2024 | Dec 31, 2024 | $175.00M | – |
| Q3 FY2024 | Sep 30, 2024 | $665.00M | -9.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.23B | +5.0% |
| Q1 FY2024 | Mar 31, 2024 | $1.11B | -9.2% |
| Q4 FY2023 | Dec 31, 2023 | -$194.00M | – |
| Q3 FY2023 | Sep 30, 2023 | $735.00M | +54.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.17B | – |
| Q1 FY2023 | Mar 31, 2023 | $1.22B | -2.8% |
| Q4 FY2022 | Dec 31, 2022 | -$282.00M | -146.8% |
| Q3 FY2022 | Sep 30, 2022 | $476.00M | -12.7% |
| Q2 FY2022 | Jun 30, 2022 | -$129.00M | – |
| Q1 FY2022 | Mar 31, 2022 | $1.25B | +18.9% |
| Q4 FY2021 | Dec 31, 2021 | $603.00M | +3920.0% |
| Q3 FY2021 | Sep 30, 2021 | $545.00M | -36.7% |
| Q2 FY2021 | Jun 30, 2021 | -$418.00M | -120.7% |
| Q1 FY2021 | Mar 31, 2021 | $1.05B | +460.6% |
| Q4 FY2020 | Dec 31, 2020 | $15.00M | -94.6% |
| Q3 FY2020 | Sep 30, 2020 | $861.00M | +389.2% |
| Q2 FY2020 | Jun 30, 2020 | $2.02B | +213.8% |
| Q1 FY2020 | Mar 31, 2020 | $188.00M | -72.6% |
| Q4 FY2019 | Dec 31, 2019 | $277.00M | -28.6% |
| Q3 FY2019 | Sep 30, 2019 | $176.00M | +329.3% |
| Q2 FY2019 | Jun 30, 2019 | $643.00M | +31.5% |
| Q1 FY2019 | Mar 31, 2019 | $685.00M | +26.9% |
| Q4 FY2018 | Dec 31, 2018 | $388.00M | +114.4% |
| Q3 FY2018 | Sep 30, 2018 | $41.00M | -87.9% |
| Q2 FY2018 | Jun 30, 2018 | $489.00M | +11.6% |
| Q1 FY2018 | Mar 31, 2018 | $540.00M | +125.0% |
| Q4 FY2017 | Dec 31, 2017 | $181.00M | -65.5% |
| Q3 FY2017 | Sep 30, 2017 | $340.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $438.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $240.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $524.00M | – |
See a number that looks wrong?